Advances in Synthetic Chemistry – Conference Announcement
Advances in Synthetic Chemistry
16-17 April 2009, Edinburgh, Scotland
Following the success of the Advances in Synthetic Chemistry conference last year, Select Biosciences is pleased to announce this year’s meeting.
Alongside an exhibition of selected scientific posters and service providers, Select Biosciences is organising a two day event, gathering some of the most influential players in the field from Europe, America and across the globe.
The agenda includes world leading research from renowned speakers including:
Mark Bradley,Professor, University of Edinburgh
Oliver Kappe, Professor, Karl-Franzens-University Graz
Mark Bagley, Lecturer, University of Cardiff
Ferenc Darvas, President, Thales Nanotechnology
Jim Thomas, Professor, Manchester University
Michael Greaney, Professor, Edinburgh University
Bruno Linclau, Senior Lecturer, University of Southampton
Stephen Clark, Head of Organic Chemistry, Glasgow University
Villem Verboom, Associate Professor, University of Twente
Erik Van der Eycken, Professor, University of Leuven
Irena Stara, Project Leader, Institute of Organic Chemistry and Biochemistry Prague
Semen Zlotsky, Professor, Ufa State Aviation Technical University
Mehul Tathagar, Research Scientist, DSM
And many more…
To guarantee a high attendance at this exciting event, Select Biosciences will maintain their traditional low registration fees and group booking discounts.
Full conference passes include admission to all sessions and the exhibition, as well as conference documentation.
Lunch, coffee breaks and the drinks reception provide ample time for networking and to continue discussions from the question and answer sessions.
The conferences division of Select Biosciences Ltd is focused on organising specialist biomedical meetings each year. Experts from both academia and commerce are invited to present timely information from current research through to commercial implementation of new technologies. These events also provide a unique networking facility and the opportunity to reach a highly targeted scientific audience.
www.selectbiosciences.com
